Abilify and Eszopiclone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Eszopiclone (eszopiclone). Common drug interactions include fall among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Eszopiclone. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,258 Eszopiclone users. Check the latest studies of Eszopiclone.



On Jul, 08, 2026

84 people who take Abilify and Eszopiclone together, and have interactions are studied.

Abilify and Eszopiclone drug interactions.

What are the common drug interactions of Abilify and Eszopiclone, by gender? *:

female:

  1. Fall
  2. Glomerulonephritis chronic (long lasting group of conditions that affect parts of the kidneys called glomeruli)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal haematoma (blood collection in kidney)
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  6. Stress urinary incontinence (leak urine with things like coughing, sneezing or exercise)
  7. Pneumonia
  8. Antinuclear antibody positive
  9. Arthralgia (joint pain)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

  1. Anxiety
  2. Drug ineffective
  3. Blood pressure decreased
  4. Coeliac artery stenosis (abnormal narrowing of coeliac artery)
  5. Gingival swelling (gums swelling)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Psychotic disorder
  8. Respiratory disorder (respiratory disease)
  9. Thrombosis (formation of a blood clot inside a blood vessel)
  10. Weight increased

What are the common drug interactions of Abilify and Eszopiclone, by age (0-1 to 60+)? *:

0-1:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Speech disorder developmental

2-9:

n/a

10-19:

n/a

20-29:

  1. Colitis ulcerative (inflammation of colon with ulcer)
  2. Restlessness (not able to rest)
  3. Abortion (termination of pregnancy)
  4. Death
  5. Erythema multiforme (a type of hypersensitivity reaction)
  6. Maternal exposure during pregnancy (use of substance during pregnancy)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

30-39:

  1. Completed suicide (act of taking one's own life)
  2. Psychiatric symptom
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Altered state of consciousness (altered state of mind)
  5. Antinuclear antibody positive
  6. Arthralgia (joint pain)
  7. Blepharospasm (any abnormal contraction or twitch of the eyelid)
  8. Blood pressure increased
  9. Cardiac failure
  10. Cervical vertebral fracture

40-49:

  1. Rash
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  3. Cough
  4. Emotional distress
  5. Hypertension (high blood pressure)
  6. Injury
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Weight increased
  9. Acute sinusitis
  10. Fatigue (feeling of tiredness)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Glomerulonephritis chronic (long lasting group of conditions that affect parts of the kidneys called glomeruli)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal haematoma (blood collection in kidney)
  6. Groin abscess (pus in groin)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Nephritic syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Abdominal discomfort

60+:

  1. Delusion (a false belief or opinion)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Irritability
  4. Salivary hypersecretion (excess saliva secretion)
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  6. Dystonia (abnormal muscle tone)
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Aphasia (damage to the parts of the brain that control language)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 13 people, 15.48%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 13.10%
  3. Pain: 10 people, 11.90%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 11.90%
  5. Bipolar Disorder (mood disorder): 9 people, 10.71%
  6. Sleep Disorder: 8 people, 9.52%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 9.52%
  8. Stress And Anxiety: 7 people, 8.33%
  9. High Blood Cholesterol: 7 people, 8.33%
  10. Drowsiness: 6 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Eszopiclone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eszopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eszopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and eszopiclone (the active ingredients of Abilify and Eszopiclone, respectively), and Abilify and Eszopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: